Intracranial Pressure (ICP) Monitoring Devices Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Intracranial Pressure (ICP) Monitoring Devices Market size is projected to witness significant growth from 2019 to 2025.
 

Growing prevalence of various neurological disorders coupled with rising occurrence of meningitis, brain infection, and aneurysm are the factors driving the intracranial pressure (ICP) monitoring devices market growth. Increasing necessity of ICP monitoring due to high incidence rate of traumatic accidents is propelling the industry size.
 

Increasing prevalence of Alzheimer’s disease is projected to boost business growth. According to the Alzheimer’s Association, in 2017, approximately 5.5 million Americans were affected by Alzheimer’s dementia. Additionally, around 5.3 million people aged 65 and above were affected by Alzheimer’s & around 200,000 individuals under age group 65 were with younger onset Alzheimer’s. Moreover, rising healthcare expenditure for diagnosis and care of these high prevalent diseases escalates the demand for ICP monitoring devices market. As per Alzheimer’s Association, healthcare costs for U.S. was USD 259 billion in 2017, and this number is projected to reach up to USD 1.1 trillion by 2050.
 

Intracranial pressure monitoring is used for diagnostics as well as post-operative procedures with neurosurgery and cranial injury. Additionally, ongoing research and huge funding provided for research on neurological disorders are determinants of spurring the development in ICP monitoring devices market. Associated excessive cost of ICP monitoring devices along with dearth of expertise in emerging nations are factors hampering the business growth.
 

Extensive applications of ICP monitor such as application in stroke, intracerebral hematoma, hepatic failure, and subarachnoid hemorrhage (SAH) will upsurge the industry size growth. Rising traumatic brain injuries coupled with strong guidelines of medical organizations and development in wireless ICP and non-invasive ICP monitoring system contributes towards business growth. Severe brain diseases cause high intracranial pressure that generates need for monitoring intracranial pressure, thus driving the market growth.
 

External ventricular drainage (EVD) of invasive technique segment accounted for major revenue share in 2018 due to high adoption rate of systems in emergency care centers and hospitals as it provides ICP measurement with high accuracy. Optic nerve sheath diameter (ONSD) segment of noninvasive technique segment is growing substantially owing to benefits such as ease of delivery and noninvasiveness.
 

Traumatic brain injury (TBI) in applications segment held major revenue share in 2018 due to its high prevalence worldwide. As per the American Association of Neurological Surgeons, annual TBI direct and indirect costs are assessed at USD 48 to 56 billion. Additionally, approximately 235,000 hospitalizations for spinal cord injuries are anticipated to boost industry growth.
 

U.S. accounted for major ICP monitoring devices market share that is attributed to high adoption rate of advanced devices, and huge patient pool with neurological disorders. According to the CDC, approximately 1.7 million cases of TBI occur in the U.S. and around 5.3 million people live with disability caused due to TBI.
 

India and China will witness lucrative growth opportunities owing to supporting government initiatives, rising patient awareness levels about neurological disorders coupled with numerous well-established critical care centers and hospitals. As per the National Institutes of Health (NIH), in 2016, the stroke incidence in India were much higher than that of western industrialized nations and huge vessel intracranial atherosclerosis is common cause for ischemic strokes in India. Such high occurrences propel business growth.
 

Some of the business players include, Medtronic, Codman & Shurtleff, Integra LifeScience, Vittamed, Orsan Medical Technologies, Sophysa, Spiegelberg, HeadSense Medical, Neural Analytics, Vivonics, and NeuroDx Development. The company players mainly concentrate on tactical mergers, partnership, and acquisitions for progress in business development. For instance, in February 2017, the Integra LifeScience announced binding acquisition offer for Johnson & Johnson Codman neurosurgery business for around 1.045 billion USD this will enhance the global position and addition of complementary product portfolio. In addition, this will also aid in expansion over international level as well as commercial capabilities as around 52% of overall revenue being outside U.S.
 

Intracranial pressure (ICP) monitoring devices market by technique, 2014-2025 (USD Million)

• Invasive  
  • External ventricular drainage (EVD) 
  • Microtransducer ICP monitoring
• Noninvasive   
  • Transcranial doppler ultrasonography 
  • Tympanic membrane displacement (TMD) 
  • Optic nerve sheath diameter
  • MRI/CT
  • Fundoscopy (papilledema)

Intracranial pressure (ICP) monitoring devices market by application, 2014-2025 (USD Million)

• Traumatic brain injury
• Meningitis
• Intracerebral hemorrhage
• Others (CNS infection, cerebral edema)

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa
  • South Africa
  • Saudi Arabia

Company Profiles:

• Medtronic
• Codman & Shurtleff 
• Integra LifeScience
• Vittamed
• Orsan Medical Technologies
• Sophysa
• Spiegelberg
• HeadSense Medical
• Neural Analytics
• Vivonics
• NeuroDx Development 

What Information does this report contain?